Description

Thalitero 50 mg contains Thalidomide is Thalidomide Capsules, an immunomodulatory agent with anti-inflammatory and anti-angiogenic properties. It is widely used in oncology, particularly in combination regimens for multiple myeloma, and in select cases of other immune-mediated disorders.

🔬 Mechanism of Action

Thalidomide works through multiple mechanisms:

• Modulates immune system activity
• Inhibits tumor necrosis factor-alpha (TNF-α)
• Suppresses abnormal blood vessel formation (anti-angiogenic effect)
• Enhances T-cell and natural killer (NK) cell activity

As a result, it helps slow cancer cell growth and progression.

💊 Indications

Thalitero 50 mg is indicated for:

• Multiple Myeloma (in combination with dexamethasone or other agents)
• Erythema Nodosum Leprosum (ENL)
• Other immune-mediated conditions as prescribed

📌 Key Features of Thalitero 50 mg

• Strength: 50 mg
• Dosage Form: Oral capsule
• Therapeutic Class: Immunomodulatory Agent (IMiD)
• Administration: Taken orally, typically at bedtime as directed
• Monitoring: Regular blood counts and neurological assessment required

⚕️ Benefits of Thalidomide

• Effective component of multiple myeloma treatment regimens
• Anti-angiogenic and immunomodulatory effects
• Oral therapy for convenient administration
• Improves response rates when combined with other therapies

⚠️ Precautions

• Highly teratogenic — strict pregnancy prevention program required
• Risk of peripheral neuropathy
• May cause sedation, constipation, and blood clots
• Increased risk of thromboembolic events (anticoagulation may be required)
• Use strictly under oncologist supervision

Thalitero 50 mg (Thalidomide Capsules) is an important immunomodulatory therapy used in the management of multiple myeloma and specific inflammatory conditions, offering effective disease control when administered under careful medical supervision.